Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study
Philip Murray, Masanobu Kawai, Moshe Phillip, Michael Højby et al.
Journal
European Journal of Endocrinology
Topics
Growth Hormone and Insulin-like Growth Factors
article
Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study
Philip Murray, Masanobu Kawai, Moshe Phillip, Michael Højby, Andrew Dauber, M Jennifer Abuzzahab, Kamil Soltysik
article en
Abstract
No abstract available for this paper.
Publication Tag
European Journal of EndocrinologyVol. 194(2)
Institutions
Children’s Minnesota - St. Paul Hospital (US), Children's National (US), Tel Aviv University (IL), Novo Nordisk (Denmark) (DK), Manchester Academic Health Science Centre (GB), Ljubljana University Medical Centre (SI), Osaka Women's and Children's Hospital (JP), Novo Nordisk (United States) (US), Schneider Children's Medical Center (IL), Royal Manchester Children's Hospital (GB)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study — Philip Murray, Masanobu Kawai, et al. · European Journal of Endocrinology (2026) | TGRS Research Map | TGRS